Weiwei Zhang

Dr. Weiwei Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
MTMei Tao
Mei Tao
MZMing Zheng
Ming Zheng
YXYanhua Xu
Yanhua Xu
SMShuo Ma
Shuo Ma
WZWeiwei Zhang
Weiwei Zhang
SJShaoqing Ju
Shaoqing Ju
Circular RNAs (circRNAs), a novel type of non-coding RNAs (ncRNAs), have a covalently closed circular structure resulting from pre-mRNA back splicing via spliceosome and ribozymes. They can be classified differently in accordance with different criteria. As circRNAs are abundant, conserved, and stable, they can be used as diagnostic markers in various diseases and targets to develop new therapies. There are various functions of circRNAs, including sponge for miR/proteins, role of scaffolds, templates for translation, and regulators of mRNA translation and stability. Without m7G cap and poly-A tail, circRNAs can still be degraded in several ways, including RNase L, Ago-dependent, and Ago-independent degradation. Increasing evidence indicates that circRNAs can be modified by N-6 methylation (m6A) in many aspects such as biogenesis, nuclear export, translation, and degradation. In addition, they have been proved to play a regulatory role in the progression of various cancers. Recently, methods of detecting circRNAs with high sensitivity and specificity have also been reported. This review presents a detailed overview of circRNAs regarding biogenesis, biomarker, functions, degradation, and dynamic modification as well as their regulatory roles in various cancers. It’s particularly summarized in detail in the biogenesis of circRNAs, regulation of circRNAs by m6A modification and mechanisms by which circRNAs affect tumor progression respectively. Moreover, existing circRNA detection methods and their characteristics are also mentioned.

7 March 2016 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
RXRong Xia
Rong Xia
SCSun-Xiao Chen
Sun-Xiao Chen
QQQin Qin
Qin Qin
YCYan Chen
Yan Chen
WZWeiwei Zhang
Weiwei Zhang
ADAnmei Deng
Anmei Deng
Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling Oridonin;ovarian cancer;mTOR signal pathway;suppress proliferation; Oridonin, an ent-kaurane diterpenoid compound isolated from the traditional Chinese herb Rabdosia rubescens, has shown various pharmacological and physiological effects such as anti-tumor, anti-bacterial, and anti-inflammatory properties. However, the effect of oridonin on human ovarian cancer cell lines has not been determined. In this study, we demonstrated that oridonin inhibited ovarian cancer cell proliferation, migration and invasion in a dose-dependent manner. Furthermore, we showed oridonin inhibited tumor growth of ovarian cancer cells (SKOV3) in vivo. We then assessed mechanisms and found that oridonin specifically abrogated the phosphorylation/activation of mTOR signaling. In summary, our results indicate that oridonin is a potential inhibitor of ovarian cancer by blocking the mTOR signaling pathway.

15 July 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
SMShuting Meng
Shuting Meng
LJLongxiao Jing
Longxiao Jing
WZWeiwei Zhang
Weiwei Zhang
FWFeng Wang
Feng Wang
YDYefeng Dong
Yefeng Dong
DDDeping Dong
Deping Dong
Background: As a chronic systemic autoimmune disease of undetermined etiology, rheumatoid arthritis (RA) has a complex pathogenesis, which involves multiple proteins and cytokines. The 2010 ACR/EULAR classification criteria facilitate early diagnosis of RA with reduced specificity when compared to the 1987 ACR criteria. Hence, it is imperative to identify novel serological inflammatory indicators and targets, in order to explain the complex regulatory network of RA. The present review discusses the associations of various inflammatory factors with RA and its underlying mechanism. Besides, the review also provides a novel insight into the clinical treatment of RA.Materials and Methods: According to the PRISMA guidelines, databases like Web of Science, Google‐Scholar, Pubmed and Scopus were systematically searched for articles from January 1, 2018 to January 1, 2022 using The following 2 keywords: "rheumatoid arthritis", "Inflammatory cytokines", "ILs", "serum amyloid protein A", "matrix metalloproteinase 3", "RANKL", "Glucose‐6‐phosphoisomerase", "Anti‐keratin antibody", "1,25‐Dihydroxyvitamin D3".Results: Indicators like MMPs, ILs, glucose‐6‐phosphate isomerase (GPI), anti‐keratin antibody (AKA) and receptor activator of nuclear factor‐κB ligand (RANKL) are the current hotspots in the efficacy research of RA. The present review suggests that ILs are highly expressed in the serum and synovial tissues of RA patients. By targeted inhibition of ILs with inhibitor application, precise RA treatment can be achieved.Conclusions: Based on these results, it can be concluded that inflammatory factors have certain guiding significance in the diagnosis and efficacy evaluation of RA. However, the mechanisms of interactions among them are rather complex, which deserve further exploration.

22 January 2024 in Environmental Toxicology
Verified
Journal Article
Closed access
JXJing Xu
Jing Xu
YWYue Wang
Yue Wang
XLXian Li
Xian Li
MZMing Zheng
Ming Zheng
YLYang Li
Yang Li
WZWeiwei Zhang
Weiwei Zhang

1 January 2024 in Biomarkers in Medicine
Verified
Journal Article
Open access
CTChenxue Tang
Chenxue Tang
JXJing Xu
Jing Xu
MZMing Zheng
Ming Zheng
DQDongchen Qian
Dongchen Qian
ZGZhihua Gao
Zhihua Gao
WZWeiwei Zhang
Weiwei Zhang
Objective: This research aimed to explore a diagnostic method based on serum ALDH3B1 and to evaluate the clinical diagnostic efficacy in gastric cancer (GC) by comparing it with the traditional GC ...